MARISSA KRZYZAN: Open Payments
NPI 1205598521 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 23 payments from 9 companies in 2025. Trend: 2023 $21 · 2024 $0 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| Novo Nordisk Inc | 9 | $147 |
| Boston Scientific Corporation | 1 | $120 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $32 |
| PFIZER INC. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: WATCHMAN, BREZTRI, AIRSUPRA, Rybelsus, REXULTI, VRAYLAR, PREVNAR 20, Wegovy.
Industry payments across NY — which companies pay providers there.
